Zentalis Pharmaceuticals Llc
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $26,865 |
Gross Profit | -160 | -262 | 26,865 | |
EBITDA | -26,531 | -34,746 | -37,565 | -45,796 |
EBIT | -26,691 | -34,906 | -37,827 | -46,113 |
Net Income | -26,691 | -26,874 | -48,279 | -47,472 |
Net Change In Cash | 0 | 0 | 0 | 26,865 |
Free Cash Flow | -26,963 | -34,708 | -32,636 | -39,702 |
Cash | 39,072 | 37,599 | 41,929 | 33,901 |
Basic Shares | 72,139 | 71,992 | 71,678 | 71,237 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $67,425 | $0 | $0 | $0 |
Gross Profit | 67,425 | -1,389 | -1,426 | -544 |
EBITDA | -186,169 | -247,599 | -225,861 | -207,198 |
EBIT | -187,458 | -248,988 | -227,287 | -207,742 |
Net Income | -165,839 | -292,191 | -236,806 | -158,725 |
Net Change In Cash | 67,425 | 0 | 0 | 0 |
Cost of Revenue | -16,888 | 6,313 | ||
Free Cash Flow | -171,081 | -208,405 | -166,299 | -160,200 |
Cash | 33,901 | 28,038 | 43,069 | 59,957 |
Basic Shares | 71,080 | 65,409 | 52,857 | 42,688 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.37 |
2025-06-30 | -$0.37 |
2025-03-31 | -$0.67 |
2024-12-31 | -$0.61 |
